Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida. Show more

501 E. Las Olas Blvd., Fort Lauderdale, FL, 33301, United States

Biotechnology

Healthcare

Market Cap

6.006M

52 Wk Range

$1.67 - $6.20

Previous Close

$2.50

Open

$2.36

Volume

4,487

Day Range

$2.36 - $2.44

Enterprise Value

4.597M

Cash

1.385M

Avg Qtr Burn

-552K

Insider Ownership

14.11%

Institutional Own.

6.64%

Qtr Updated

12/31/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Ad-RTS-hIL-12 + veledimex (Controlled IL-12) Details Glioblastoma, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Ad-RTS-hIL-12 + veledimex (Controlled IL-12) Details Glioblastoma, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Ad-RTS-hIL-12 + veledimex (Controlled IL-12) Details Glioblastoma, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TCR-T targeting neoantigens Details Cancer, Solid tumor/s	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.